ACP
MTEM

Acuta Capital Partners’s Molecular Templates, Inc. MTEM Stock Holding History

Acuta Capital Partners’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,475
Closed -$1.06M – 53
2022
Q1 		$1.06M Sell
20,475
-1,025
-5% -$45.3K 0.5% 33
2021
Q4 		$1.26M Buy
+21,500
New +$1.61M 0.53% 33

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acuta Capital Partners's MTEM Position: Q2 2022 in Review

Acuta Capital Partners sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 20,475 shares — an estimated $1.06M sold.

Acuta Capital Partners first reported a position in MTEM in Q4 2021 and held it in 2 quarters. The position peaked at $1.26M in Q4 2021. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

  • Acuta Capital Partners reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
  • Acuta Capital Partners sold 20,475 Molecular Templates, Inc. shares in Q2 2022, an estimated $1.06M.
  • Acuta Capital Partners first reported a position in Molecular Templates, Inc. in Q4 2021 and held it in 2 quarters.
  • Acuta Capital Partners's Molecular Templates, Inc. position peaked at $1.26M in Q4 2021.
  • 65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Acuta Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.